2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Memory Impairment: new trials by email Literature Review of Memory Impairment trials Research Report on Memory Impairment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil Donepezil 5 mg, Placebo - Cognitive Dysfunction, Memory Impairment | Phase 3 | Completed | Wake Forest University Health Sciences | 276 | 2017-05-30 | 2023-09-13 |
| The Healthy Patterns Sleep Study Attention-Control Condition, Timed Activity Intervention - Dementia, Alzheimer Disease | Phase 3 | Completed | University of Pennsylvania | 421 | 2016-05-01 | 2024-07-26 |
Cognitive Dysfunction (2) · Memory Disorders (2) · Alzheimer Disease (1) · Breast Neoplasms (1) · Chronobiology Disorders (1) · Dementia (1) · Dementia, Vascular (1) · Disorders of Excessive Somnolence (1) · Frontotemporal Dementia (1) · Neurocognitive Disorders (1) · Psychomotor Agitation (1) · Sleep Disorders, Circadian Rhythm (1) · Sleep Initiation and Maintenance Disorders (1) · Sleep Wake Disorders (1)
Cognition Disorders (2) · Mental Disorders (2) · Nervous System Diseases (2) · Neurobehavioral Manifestations (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Aberrant Motor Behavior in Dementia (1) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Behavior (1) · Behavioral Symptoms (1) · Brain Diseases (1) · Breast Diseases (1) · Cardiovascular Diseases (1)
University of Pennsylvania (1) · Wake Forest University Health Sciences (1)
United States (2)
Nancy A. Hodgson (1) · Stephen R Rapp, PhD (1)
PMID 33853394, PMID 34344312, PMID 38709986
3UG1CA189824-04S1 (1), R01NR015226 (1)